Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $13.76 billion. The enterprise value is $13.75 billion.
| Market Cap | 13.76B |
| Enterprise Value | 13.75B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 94.52 million shares outstanding. The number of shares has increased by 12.39% in one year.
| Shares Outstanding | 94.52M |
| Shares Change (YoY) | +12.39% |
| Shares Change (QoQ) | -4.48% |
| Owned by Insiders (%) | 4.43% |
| Owned by Institutions (%) | 88.55% |
| Float | 90.23M |
Valuation Ratios
The trailing PE ratio is 364.03 and the forward PE ratio is 27.56. SRPT's PEG ratio is 159.25.
| PE Ratio | 364.03 |
| Forward PE | 27.56 |
| PS Ratio | 9.81 |
| Forward PS | 6.38 |
| PB Ratio | 14.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | 159.25 |
Enterprise Valuation
| EV / Earnings | 813.89 |
| EV / Sales | 9.80 |
| EV / EBITDA | 150.92 |
| EV / EBIT | 403.76 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.05, with a Debt / Equity ratio of 1.44.
| Current Ratio | 4.05 |
| Quick Ratio | 2.91 |
| Debt / Equity | 1.44 |
| Debt / EBITDA | 15.14 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.00% and return on invested capital (ROIC) is -2.01%.
| Return on Equity (ROE) | 2.00% |
| Return on Assets (ROA) | 0.50% |
| Return on Capital (ROIC) | -2.01% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | $12,859 |
| Employee Count | 1,314 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 0.35 |
Taxes
In the past 12 months, SRPT has paid $17.16 million in taxes.
| Income Tax | 17.16M |
| Effective Tax Rate | 50.39% |
Stock Price Statistics
The stock price has increased by +37.49% in the last 52 weeks. The beta is 0.88, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +37.49% |
| 50-Day Moving Average | 136.38 |
| 200-Day Moving Average | 118.00 |
| Relative Strength Index (RSI) | 50.95 |
| Average Volume (20 Days) | 2,233,086 |
Short Selling Information
The latest short interest is 9.56 million, so 10.11% of the outstanding shares have been sold short.
| Short Interest | 9.56M |
| Short Previous Month | 9.46M |
| Short % of Shares Out | 10.11% |
| Short % of Float | 10.59% |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, SRPT had revenue of $1.40 billion and earned $16.90 million in profits. Earnings per share was $0.40.
| Revenue | 1.40B |
| Gross Profit | 1.24B |
| Operating Income | -94.83M |
| Pretax Income | 34.06M |
| Net Income | 16.90M |
| EBITDA | 91.13M |
| EBIT | 34.06M |
| Earnings Per Share (EPS) | $0.40 |
Balance Sheet
The company has $1.39 billion in cash and $1.38 billion in debt, giving a net cash position of $11.40 million or $0.12 per share.
| Cash & Cash Equivalents | 1.39B |
| Total Debt | 1.38B |
| Net Cash | 11.40M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 961.19M |
| Book Value Per Share | 10.17 |
| Working Capital | 1.86B |
Cash Flow
In the last 12 months, operating cash flow was -$533.67 million and capital expenditures -$99.07 million, giving a free cash flow of -$632.74 million.
| Operating Cash Flow | -533.67M |
| Capital Expenditures | -99.07M |
| Free Cash Flow | -632.74M |
| FCF Per Share | -$6.73 |
Margins
Gross margin is 88.18%, with operating and profit margins of -6.76% and 1.20%.
| Gross Margin | 88.18% |
| Operating Margin | -6.76% |
| Pretax Margin | 2.43% |
| Profit Margin | 1.20% |
| EBITDA Margin | 6.49% |
| EBIT Margin | 2.43% |
| FCF Margin | -45.09% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.39% |
| Shareholder Yield | -12.39% |
| Earnings Yield | 0.12% |
| FCF Yield | -4.60% |
Analyst Forecast
The average price target for SRPT is $187.00, which is 28.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $187.00 |
| Price Target Difference | 28.43% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 26.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 2.89 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.89 |
| Piotroski F-Score | 5 |